These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 9554797)
1. Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction. Van Den Heuvel AF; van der Ent M; van Veldhuisen DJ; Kruijssen DA; Bartels GL; Remme WJ J Cardiovasc Pharmacol; 1998 Apr; 31(4):506-12. PubMed ID: 9554797 [TBL] [Abstract][Full Text] [Related]
2. Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease. Venneker EH; Remme WJ; van Hoogenhuyze DC; Krauss XH; Bartels GL; Kruijssen DA; Storm CJ; van Schelven D Cardiovasc Drugs Ther; 1994 Apr; 8(2):211-9. PubMed ID: 7918133 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol. Simon G; Wittig VJ J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403 [TBL] [Abstract][Full Text] [Related]
4. Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function. Bartels GL; van den Heuvel FM; van Veldhuisen DJ; van der Ent M; Remme WJ Am J Cardiol; 1999 Feb; 83(3):332-6. PubMed ID: 10072218 [TBL] [Abstract][Full Text] [Related]
5. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris. Vandenbosch H; Piessens J; De Geest H Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394 [TBL] [Abstract][Full Text] [Related]
6. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion. Masson S; Masseroli M; Fiordaliso F; Calvillo L; D'Aquila S; Bernasconi R; Garrido G; Torri M; Razzetti R; Bongrani S; Latini R J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987 [TBL] [Abstract][Full Text] [Related]
7. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function. Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052 [TBL] [Abstract][Full Text] [Related]
8. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring. Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985 [TBL] [Abstract][Full Text] [Related]
9. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group. Boberg J; Larsen FF; Pehrsson SK Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086 [TBL] [Abstract][Full Text] [Related]
10. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy. Akhras F; Jackson G Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977 [TBL] [Abstract][Full Text] [Related]
11. Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris. Remme WJ; de Leeuw PW; Bootsma M; Look MP; Kruijssen DA Am J Cardiol; 1991 Jul; 68(2):181-6. PubMed ID: 2063779 [TBL] [Abstract][Full Text] [Related]
12. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure. Omvik P; Lund-Johansen P; Haugland H Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925 [TBL] [Abstract][Full Text] [Related]
13. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation; 2000 Feb; 101(4):378-84. PubMed ID: 10653828 [TBL] [Abstract][Full Text] [Related]
15. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease]. Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns. Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431 [TBL] [Abstract][Full Text] [Related]
17. Effect of antiischemic therapy on coronary flow reserve and the pressure-maximal coronary flow relationship in anesthetized swine. McFalls EO; Duncker DJ; Sassen LM; Gho BC; Verdouw PD J Cardiovasc Pharmacol; 1991 Dec; 18(6):827-36. PubMed ID: 1725894 [TBL] [Abstract][Full Text] [Related]
18. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris. Readman AS Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983 [TBL] [Abstract][Full Text] [Related]
19. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin. Lefebvre RA; Bogaert MG; Duprez D Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206 [TBL] [Abstract][Full Text] [Related]
20. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Yaoita H; Sakabe A; Maehara K; Maruyama Y Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]